8-KOther Events

ABBOTT LABORATORIES 8-K Report (Jan 16, 2004)

Filed January 16, 2004For Securities:ABT

Summary

Abbott Laboratories (ABT) filed an 8-K on January 16, 2004, to announce its financial results for the fourth quarter and full year of 2003. The report includes a press release that details these results, which are presented using both GAAP and non-GAAP financial measures. Management utilizes these non-GAAP measures, such as net earnings and diluted earnings per share excluding one-time charges, to provide a clearer view of ongoing business performance and operational trends, adjusting for unusual or unpredictable factors. Investors are encouraged to review these non-GAAP figures alongside the standard GAAP financials. Abbott's management finds these adjusted metrics valuable for internal performance monitoring and believes they offer investors enhanced insight into the company's underlying operational health. The press release serves as the primary document containing these detailed financial disclosures for the period.

Key Highlights

  • 1Abbott Laboratories announced its fourth quarter and full year 2003 financial results on January 16, 2004.
  • 2The 8-K filing includes a press release detailing these financial results.
  • 3The company utilized non-GAAP financial measures in its reporting, including net earnings and diluted earnings per share excluding one-time charges.
  • 4These non-GAAP measures are presented to offer investors a view of ongoing business performance by excluding unusual or unpredictable items.
  • 5Abbott's management believes these adjusted figures provide useful information for evaluating business performance.
  • 6Investors are advised to consider these non-GAAP measures in conjunction with, not as a substitute for, GAAP financial measures.

Frequently Asked Questions

This 8-K filing serves to announce Abbott Laboratories' financial results for the fourth quarter and the full year of 2003, as detailed in an accompanying press release.

Abbott reported its financial results using both Generally Accepted Accounting Principles (GAAP) and non-GAAP financial measures. The non-GAAP measures included adjustments for one-time charges, such as adjusted net earnings and diluted earnings per share excluding these charges.

Abbott's management uses non-GAAP financial measures to provide investors with a better understanding of the company's ongoing business performance by excluding items that are unusual or unpredictable. These measures are also used internally for performance monitoring.

Investors should consider these non-GAAP financial measures in addition to, and not as a substitute for, the financial measures prepared in accordance with GAAP. They are intended to offer a supplemental view of the company's operational health.